Typhoid fever produces a major burden of mortality and morbidity worldwide, yet the problem is most prominent in south Asia and African countries. The overall current mortality rate has been reduced to less than 1% due to advancements in treatment modalities and the manufacture of antibiotics as compared to 12.75% in the 1940s when treatment was mainly symptomatic and supportive.